Bulletin
Investor Alert

New York Markets Open in:

Cabaletta Bio Inc.

NAS: CABA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 17, 2022, 6:26 p.m.

/zigman2/quotes/214676209/composite

$

1.48

Change

+0.12 +8.82%

Volume

Volume 6,328

Quotes are delayed by 20 min

/zigman2/quotes/214676209/composite

Previous close

$ 1.50

$ 1.36

Change

-0.14 -9.33%

Day low

Day high

$1.35

$1.50

Open

52 week low

52 week high

$0.90

$14.95

Open

Insider Actions for Cabaletta Bio Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/31/2022 Steven Nichtberger
President & CEO; Director
50,000   Derivative/Non-derivative trans. at $1.01 per share. 50,500
11/01/2021 5AM Venture Management LLC
36,544   Disposition at $13 per share. 475,072
11/01/2021 5AM Venture Management LLC
258,456   Disposition at $13 per share. 3,359,928
09/07/2021 5AM Venture Management LLC
625,000   Disposition at $9.7 per share. 6,062,500
01/12/2021 5AM Venture Management LLC
10,530   Disposition at $13 per share. 136,890
01/12/2021 5AM Venture Management LLC
74,470   Disposition at $13 per share. 968,110
01/08/2021 5AM Venture Management LLC
37,411   Disposition at $13 per share. 486,343
01/08/2021 5AM Venture Management LLC
264,589   Disposition at $13 per share. 3,439,657
12/10/2020 5AM Venture Management LLC
36,916   Disposition at $14.75 per share. 544,511
12/10/2020 5AM Venture Management LLC
261,084   Disposition at $14.75 per share. 3,850,989
10/29/2019 5AM Venture Management LLC
454,545   Acquisition at $11 per share. 4,999,995
10/29/2019 Deerfield Management Company LP
700,000   Acquisition at $11 per share. 7,700,000
10/29/2019 5AM Venture Management LLC
3,214,721   Derivative/Non-derivative trans. at $0 per share. 0
10/29/2019 Deerfield Management Company LP
464,253   Derivative/Non-derivative trans. at $0 per share. 0
10/29/2019 Deerfield Management Company LP
464,253   Derivative/Non-derivative trans. at $0 per share. 0
10/29/2019 Steven Nichtberger
President & CEO; Director
60,483   Derivative/Non-derivative trans. at $0 per share. 0
10/29/2019 Redmile Group LLC
696,378   Derivative/Non-derivative trans. at $0 per share. 0
10/29/2019 Mark Simon
Director
18,144   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
1 Purchases
3 Sales
50,000
920,000

Officers and Executives

Dr. Steven Nichtberger
Chairman, President & Chief Executive Officer
Mr. Anup Marda
Chief Financial & Accounting Officer
Dr. Gwendolyn Binder-Scholl
President-Science & Technology
Dr. David J. Chang
Chief Medical Officer
Dr. Samik Basu
Chief Scientific Officer
Dr. Arun Das
Chief Business Officer
Ms. Heather Harte-Hall
Chief Compliance Officer
Ms. Martha O'Connor
Chief Human Resources Officer
Mr. Michael Gerard
General Counsel
Dr. Scott Brun
Independent Director
Mr. Mark Simon
Independent Director
Mr. Richard C. Henriques
Independent Director
Dr. Catherine Bollard
Independent Director
Link to MarketWatch's Slice.